PATENT CLAIM ANALYSIS

Application Number: 15969568
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "365000"]

Abstract:
The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.

Claim (Index 26):
A unit dosage form comprising:\n (i) baclofen or a pharmaceutically acceptable salt thereof in an amount between about 1 and about 300 \u03bcg/kg of a human subject, (ii) sorbitol or a pharmaceutically acceptable salt thereof, and (iii) naltrexone or a pharmaceutically acceptable salt thereof in an amount between about 1 and about 100 \u03bcg/kg of the human subject; and a pharmaceutically acceptable excipient or carrier.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 93.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15390972', '15212748', '15137801', '14187841', '14269783']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8515171510259982
- 35 USC 102 Novelty (BERT): 0.6989185799612786
- Combined Prediction Score: 0.8362572939195263
- Mean Citation Score: 672.089474
- Max Citation Score: 751.74927
- Similarity Product: 724.2933222913637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test